A Phase 2 interventional study of cobimetinib in extracranial arteriovenous malformations
Completed Phase 2 NCT05125471
Study Description
Evaluating the safety and effectiveness of cobimetinib in treating extracranial arteriovenous malformations
Study Details
- Registry ID:
- NCT05125471
- Conditions:
- Arteriovenous Malformations (Extracranial)
- Phase:
- Phase 2
- Target Enrollment:
- 3 participants
- Start Date:
- Age Range:
- 2–80 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.